Clinical Trial Update: Observational, Postmarketing Surveillance Study of Spinraza Injection (Nusinersen Sodium)

View source ↗

Summary

This is an observational postmarketing surveillance study of nusinersen (Spinraza) for spinal muscular atrophy. It is sponsored by Biogen and is currently activ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Muscular Atrophy

Drugs mentioned

• Spinraza (nusinersen)

Snippet

Sponsor: Biogen | Conditions: Muscular Atrophy, Spinal | Status: ACTIVE_NOT_RECRUITING